Skip to content
Home/Companies/MedTech/Biolog-id
Biolog-id

Biolog-id

MedTech·France·Active·4yr hold
Entry
2022
Hold
4yr
Status
Active

Who owns Biolog-id?

Biolog-id is a French MedTech company, currently owned by Xerys Invest since 2022.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
Xerys Invest
Investor
Xerys Invest
Xerys Capital France · 2014 · Growth

Key facts

HQFrance
SectorMedTech
Websitewww.biolog-id.com

More from Xerys Capital France

Other portfolio companies in the same fund.

PowiDian Mobility / LMI
Active
France· 2021
Optionizr
Optionizr
Exited 2025
TMTFrance· 2018
to SoftNext
7Hugs Labs
Exited 2020
SoftwareFrance· 2017
to Qorvo
AlzProtect
AlzProtect
Active
BiotechFrance· 2017
Advanced BioDesign
Advanced BioDesign
Active
BiotechFrance· 2016
Powidian
Active
ClimateTechFrance· 2016

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to Bausch + Lomb
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to Omnicell
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany

Questions

Who owns Biolog-id?

Biolog-id is currently owned by Xerys Invest, through Xerys Capital France, since 2022.

When did Xerys Invest acquire Biolog-id?

Xerys Invest acquired Biolog-id in 2022.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue